Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP763681.RAnRvjM76fotXY6EbInJDj_4dyaAHZ2EdBcVEb-VzZ0RQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP763681.RAnRvjM76fotXY6EbInJDj_4dyaAHZ2EdBcVEb-VzZ0RQ130_assertion type Assertion NP763681.RAnRvjM76fotXY6EbInJDj_4dyaAHZ2EdBcVEb-VzZ0RQ130_head.
- NP763681.RAnRvjM76fotXY6EbInJDj_4dyaAHZ2EdBcVEb-VzZ0RQ130_assertion description "[KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763681.RAnRvjM76fotXY6EbInJDj_4dyaAHZ2EdBcVEb-VzZ0RQ130_provenance.
- NP763681.RAnRvjM76fotXY6EbInJDj_4dyaAHZ2EdBcVEb-VzZ0RQ130_assertion evidence source_evidence_literature NP763681.RAnRvjM76fotXY6EbInJDj_4dyaAHZ2EdBcVEb-VzZ0RQ130_provenance.
- NP763681.RAnRvjM76fotXY6EbInJDj_4dyaAHZ2EdBcVEb-VzZ0RQ130_assertion SIO_000772 22836042 NP763681.RAnRvjM76fotXY6EbInJDj_4dyaAHZ2EdBcVEb-VzZ0RQ130_provenance.
- NP763681.RAnRvjM76fotXY6EbInJDj_4dyaAHZ2EdBcVEb-VzZ0RQ130_assertion wasDerivedFrom befree-20140225 NP763681.RAnRvjM76fotXY6EbInJDj_4dyaAHZ2EdBcVEb-VzZ0RQ130_provenance.
- NP763681.RAnRvjM76fotXY6EbInJDj_4dyaAHZ2EdBcVEb-VzZ0RQ130_assertion wasGeneratedBy ECO_0000203 NP763681.RAnRvjM76fotXY6EbInJDj_4dyaAHZ2EdBcVEb-VzZ0RQ130_provenance.